Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
GA-10 (Clone 20) is a subclone of the GA-10 (ATCC CRL-2392) cell line derived by culturing the parental line on semi-solid medium conditioned by a feeder layer.
GA-10 was derived in 1996 from lymphoma cells circulating in the peripheral blood of a patient with a clinically aggressive, chemo-refractory Burkitt's Lymphoma.
This clone of cells also expresses high levels of CD77 (80-90%); CD77 is also known as Burkitt's lymphoma antigen (BLA).
GA-10 (Clone-20) cells exhibit marked sensitivity to Shiga Toxin (Stx) in cytotoxicity studies.
Medium Renewal: Every 2 to 3 days
Complete growth medium described above supplemented with 5% (v/v) DMSO. Cell culture tested DMSO is available as ATCC Catalog No. 4-X.
Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC.
Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988.
Fleming, D.O., Richardson, J. H., Tulis, J.J. and Vesley, D., (1995) Laboratory Safety: Principles and Practice. Second edition, ASM press, Washington, DC.
